NCT05997771

Brief Summary

The purpose of the study is to assess the usability of the PNA and satisfaction with the treatment within the framework of usual care remote nutritional counselling for GLP-1-supported weight management and collect pilot data on its potential to support weight loss.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

August 25, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2024

Completed
Last Updated

June 4, 2024

Status Verified

June 1, 2024

Enrollment Period

8 months

First QC Date

June 15, 2023

Last Update Submit

June 3, 2024

Conditions

Keywords

Nutritional counsellingPersonalised nutritionDietary adviceUsability

Outcome Measures

Primary Outcomes (3)

  • Change in the overall mean satisfaction score of the Nutritional and Dietetic Patient Outcomes Questionnaire (NDPOQ)

    This outcome will evaluate the patient treatment satisfaction with the counselling of the "Personal Nutrition Advisor" (PNA) -assisted remote nutritional counselling. The NDPOQ includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 15 questions.

    From baseline to 3 months of the respective study period

  • The overall mean score of the "perceived impact" section from the user version of the mobile application scale (uMARS )

    This outcome will evaluate patient satisfaction with the counselling of the "Personal Nutrition Advisor" (PNA) -assisted remote nutritional counselling. The uMARS includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 5 questions.

    Post intervention visit (3 months after baseline)

  • The overall mean score of the Healthcare Systems Usability Scale (HSUS)

    This outcome will evaluate dietitian reported usability of the "Personal Nutrition Advisor" (PNA)- assisted remote nutritional counselling. HSUS includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 20 questions.

    Post intervention visit (3 months after baseline)

Secondary Outcomes (15)

  • Change in self reported weight (%)

    From baseline to 3 months of the respective study period

  • Proportion of patients reaching >5% weight loss

    At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period

  • Proportion of patients reaching >10% weight loss

    At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period

  • Proportion of patients reaching >15% weight loss

    At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period

  • Change in daily number of logged meals and beverages

    From the first day of the respective study period to 3 months thereafter

  • +10 more secondary outcomes

Study Arms (1)

Study Intervention Group

EXPERIMENTAL

The study intervention group will be undergoing 3 months of Personalized Nutrition Advisor (PNA)-assisted remote nutritional counselling.The PNA data analysis tool will be used by the dietitians during remote nutritional counselling sessions.The service will be delivered to patients undergoing GLP-1 based obesity treatment as part of their usual care. The study intervention group will report treatment-satisfaction and self-efficacy via questionnaires at baseline, 1.5 - and 3 months. Patients who expressed their interest in participating in a focus group at the time of study inclusion, will be invited for a 60 min online interview session chaired by an experienced moderator. The focus group will consists of a maximum of 10 participants and address the patient's perspective on the utility of the dietitians' advice, discrepancy from expectations, general feedback and suggestions for PNA improvement using a semi structured discussion guide held in an open and spontaneous format

Other: Personal Nutrition Advisor

Interventions

The study intervention will be the use of the PNA data analysis tool during remote nutritional counselling sessions delivered by certified dietitians, also referred to as PNA-assisted remote nutritional counselling.

Study Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • Receiving GLP-1-based pharmacotherapy in combination with remote nutritional counselling
  • Achieved weight loss of ≥5 (for baseline BMI 28-35 kg/m2) or ≥7% (for baseline BMI≥35kg/m2) after 4 months of GLP-1 based therapy (1st milestone)

You may not qualify if:

  • Inability to give written informed consent
  • Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
  • Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
  • Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
  • Not proficient in German

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lia Bally, MD-PhD

    Inselspital University Hospital Bern, University of Bern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The evaluation of the usability will be done using a prospective single arm design (n=80). In addition, we will collect data regarding the efficacy of the intervention by comparing results of the study participants to results of historical controls (n=80). Historical controls are patients receiving the same usual care dietary counselling as the study participants but without assistance by the personal nutrition advisor.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.med. et Dr. phil.

Study Record Dates

First Submitted

June 15, 2023

First Posted

August 18, 2023

Study Start

August 25, 2023

Primary Completion

April 22, 2024

Study Completion

May 6, 2024

Last Updated

June 4, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.

Shared Documents
STUDY PROTOCOL
Time Frame
After publication of the study results in a peer-reviewed journal
Access Criteria
Contact with an approval by the corresponding author

Locations